Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nucleic Acids Symposium Series (2004)|September 9, 2008
Interactions between antitumor drugs and vault RNATsukasa Mashima, Michiko Kudo, Yusuke Takada, et al.
International Journal of Biological Macromolecules|November 25, 2010
Study of a novel glycoconjugate, thiopeptidoglycan, and a novel polysaccharide lyase, thiopeptidoglycan lyaseKeiko Kondo, Minoru Takeda, Wataru Ejima, et al.
Nucleic Acid Therapeutics|September 29, 2020
Improved Anti-Prion Nucleic Acid Aptamers by Incorporation of Chemical ModificationsJussara Amato, Tsukasa Mashima, Yuji O Kamatari, et al.
Nucleic Acids Symposium Series (2004)|September 9, 2008
Structural analysis of Musashi-RNA complex on the basis of long-range structural informationTakako Ohyama, Ayako Furukawa, Tsukasa Mashima, et al.
Molecules (Basel, Switzerland)|November 17, 2017
DNA G-Wire Formation Using an Artificial Peptide is Controlled by Protease ActivityKenji Usui, Arisa Okada, Shungo Sakashita, et al.
Nucleic Acids Research|November 28, 2012
Anti-prion activity of an RNA aptamer and its structural basisTsukasa Mashima, Fumiko Nishikawa, Yuji O Kamatari, et al.
Scientific Reports|March 20, 2020
Development and structural determination of an anti-PrP<sup>C</sup> aptamer that blocks pathological conformational conversion of prion proteinTsukasa Mashima, Joon-Hwa Lee, Yuji O Kamatari, et al.
Plos One|October 26, 2018
Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosisYukiko Ohara, Yuriko Ozeki, Yoshitaka Tateishi, et al.
Plos One|August 27, 2021
Correction: Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosisYukiko Ohara, Yuriko Ozeki, Yoshitaka Tateishi, et al.
The Journal of Experimental Medicine|March 30, 2016
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNAKazuya Masuda, Barry Ripley, Kishan Kumar Nyati, et al.
Pageof 4